Delivery Order SPE2DB25D3201-SPE2DB25FNSND
Award Date
4/18/25
Potential Completion Date
5/9/25
Potential Value
$7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,253.45, is for the supply of 4,567,958,190 units of the pharmaceutical product GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The contract has an ultimate completion date of May 8, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,950.56, is for the provision of the pharmaceutical product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The contract has an ultimate completion date of December 26, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,327.20, is for the delivery of GAMUNEX-C 40 gram/400 ml vials, with a performance period through May 9, 2025. The contract is not set aside and was awarded on an open competition basis. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,963.20, is for the delivery of GAMUNEX-C 40 gram/400 ml vials, a specialty medication. The contract has an ultimate completion date of February 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a $6,981.60 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GAMUNEX-C 40 gram/400 ML vials, a critical medical commodity, to support federal healthcare programs. The contract has a completion date of February 28, 2025 and was awarded on February 6, 2025. There is no set-aside designation noted for this award. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,981.60, is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 28, 2025. The contract is not designated as a set-aside award. AmerisourceBergen Drug Corp...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $9,722.10 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,564,743,440 units of the pharmaceutical product GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, with a completion date of June 20, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which allows the...
This is a $34,908.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML medical products. The contract has an ultimate completion date of February 28, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,544.00, is for the delivery of GAMUNEX-C 40 gram/400 mL vials, a pharmaceutical product, with a performance period extending through May 7, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award, valued at $6,981.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a delivery order for 4,567,055,865 units of the pharmaceutical product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The contract has an ultimate completion date of February 18, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to federal government agencies, including the...